Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.980
+0.080 (1.63%)
Sep 28, 2026, 3:30 PM EDT - Market open
Champions Oncology Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Cash & Equivalents | 4.36 | 4.87 | 9.79 | 2.62 | 10.12 | 9.01 |
Cash & Short-Term Investments | 4.36 | 4.87 | 9.79 | 2.62 | 10.12 | 9.01 |
Cash Growth | -57.79% | -50.21% | 273.76% | -74.13% | 12.34% | 92.17% |
Receivables | 13.6 | 13.18 | 11.2 | 9.53 | 8.01 | 9.51 |
Prepaid Expenses | 1.33 | 1.17 | 1.37 | 1.5 | 1.33 | 1.14 |
Total Current Assets | 19.29 | 19.22 | 22.36 | 13.64 | 19.46 | 19.66 |
Property, Plant & Equipment | 13.46 | 7.22 | 9.46 | 11.97 | 14.5 | 15.36 |
Goodwill | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
Other Long-Term Assets | 0.2 | 0.21 | 0.2 | 0.19 | 0.02 | 0.02 |
Total Assets | 33.29 | 26.99 | 32.34 | 26.13 | 34.31 | 35.38 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Accounts Payable | 5.63 | 6.9 | 4.25 | 5.8 | 5.33 | 2.87 |
Accrued Expenses | 2.68 | 2.59 | 2.56 | 2.16 | 2.27 | 2.41 |
Current Portion of Leases | 0.87 | 1.6 | 1.61 | 1.34 | 1.21 | 1.05 |
Current Unearned Revenue | 9.55 | 8.83 | 15.44 | 12.09 | 12.78 | 11.07 |
Other Current Liabilities | - | - | - | 0.15 | 0.15 | 0.07 |
Total Current Liabilities | 18.73 | 19.92 | 23.85 | 21.54 | 21.73 | 17.48 |
Long-Term Leases | 10.1 | 3 | 4.72 | 6.09 | 7.39 | 8.41 |
Other Long-Term Liabilities | - | - | - | 0.4 | 0.55 | 0.39 |
Total Liabilities | 28.83 | 22.92 | 28.57 | 28.04 | 29.68 | 26.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 86.08 | 85.7 | 84.36 | 83.38 | 82.01 | 81.06 |
Retained Earnings | -81.49 | -81.07 | -79.89 | -84.59 | -77.32 | -71.98 |
Treasury Stock | -0.71 | -0.71 | -0.71 | -0.71 | -0.07 | - |
Total Common Equity | 3.89 | 3.94 | 3.77 | -1.9 | 4.64 | 9.1 |
Minority Interest | 0.57 | 0.13 | - | - | - | - |
Shareholders' Equity | 4.46 | 4.07 | 3.77 | -1.9 | 4.64 | 9.1 |
Total Liabilities & Equity | 33.29 | 26.99 | 32.34 | 26.13 | 34.31 | 35.38 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 |
Total Debt | 10.97 | 4.6 | 6.33 | 7.43 | 8.6 | 9.47 |
Net Cash (Debt) | -6.61 | 0.27 | 3.46 | -4.81 | 1.52 | -0.46 |
Net Cash Growth | - | -92.08% | - | - | - | - |
Net Cash Per Share | -0.48 | 0.02 | 0.24 | -0.36 | 0.11 | -0.03 |
Filing Date Shares Outstanding | 13.92 | 13.89 | 13.78 | 13.59 | 13.46 | 13.52 |
Total Common Shares Outstanding | 13.92 | 13.89 | 13.78 | 13.59 | 13.54 | 13.52 |
Working Capital | 0.56 | -0.7 | -1.5 | -7.9 | -2.28 | 2.19 |
Book Value Per Share | 0.28 | 0.28 | 0.27 | -0.14 | 0.34 | 0.67 |
Tangible Book Value | 3.56 | 3.6 | 3.44 | -2.24 | 4.3 | 8.76 |
Tangible Book Value Per Share | 0.26 | 0.26 | 0.25 | -0.16 | 0.32 | 0.65 |
Machinery | 13.63 | 12.96 | 12.73 | 12.9 | 11.74 | 9.82 |
Construction In Progress | 0.12 | 0.21 | 0.12 | 0 | 1.08 | 0.18 |
Leasehold Improvements | 0.36 | 0.36 | 0.32 | 0.32 | 0.11 | 0.11 |